Zoom-In on Champalimaud: Ana Beatriz Machado

On September 15th 2022, the António Champalimaud Vision Award was attributed to two physician-scientists, both of them ophthalmologists, for their pioneering work in the understanding and treatment of corneal disease. Gerrit Melles from the Netherlands Institute for Innovative Ocular Surgery, and Claes Dohlman, from Mass Eye & Ear and Harvard University, shared the prestigious one million euro award – the former for his innovative surgical methods of corneal transplant, the latter for his advancement of cornea research and the development of an artificial cornea, the “Boston K-Pro”.

Zoom-In on Champalimaud: Liad Hollender

For many years, corneal injuries or disorders have been one of the leading causes of blindness across the world. The two physician-scientists have decisively changed and accelerated the path to the treatment of these problems. A deeper understanding of the transparent outer layer of the eye, as well as the possibility of ensuring an improved and more cost-effective approach to corneal surgery and transplantation, are essential to tackle this plight.

Zoom-In on Champalimaud: Ana Saraiva Ayash

Zoom-In on Champalimaud: Gonçalo Cotovio

I graduated from NOVA Medical School in 2014, before joining the Champalimaud Foundation’s Neuropsychiatry Unit (NPU) as a research intern the following year. Principally, I have been working on secondary bipolar disorder neuroimaging. 

Since then, I have been fortunate enough to train and work in a variety of institutions, including Centro Hospitalar de Lisboa Ocidental, Harvard Medical School, and since 2017 I have been completing my PhD through a FCT scholarship at the NPU.

Zoom-In on Champalimaud: Charlotte (Charlie) Rosher

Before entering the Champalimaud Foundation, I studied Evolutionary Biology on a Master’s programme that rotated around universities in Uppsala (Sweden), Montpellier (France), Munich (Germany) and Boston (USA). I love seeing the world through the lens of evolution but I have always been focussed in some way on brains and behaviour. Now I am investigating emotions and defensive behaviours for my PhD in the Behavioural Neuroscience lab (Moita lab). 

The Champalimaud Foundation and the IAEA are thus starting a partnership for the development of research, treatment and diagnosis of oncological diseases. The collaboration focuses on the areas of radiation oncology, diagnostic medical imaging, nuclear medicine and medical physics.

Zoom-In on Champalimaud: Justyna Kociolek

Zoom-In on Champalimaud: Ana Carolina Pádua

I hold a Master’s degree in Biomedical Engineering and a PhD in Molecular Biosciences from NOVA University, Lisbon. After completing my PhD project, I moved to Texas (USA) for an internship in High-Performance Computing. This experience allowed me to discover how supercomputers can contribute to making science more efficient and productive.